Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Z Böcskei

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Acta Pharmaceutica Hungarica|April 7, 1998
[Application of protein crystallography in drug design]Z Böcskei
Cell|August 8, 1998
Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysisV Fülöp, Z Böcskei, L Polgár
Acta Pharmaceutica Hungarica|September 1, 1992
[Study of selegiline and related compounds with x-ray diffraction]K Simon, Z Böcskei, Z Török
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1995
Two antithrombotic quinazolone derivativesZ Böcskei, K Simon, L Orfi, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1996
Ipriflavone, an antiostheophorotic agentZ Böcskei, K Simon, M Varga, et al.
European Journal of Biochemistry|August 3, 1999
The three-dimensional structure of Asp189Ser trypsin provides evidence for an inherent structural plasticity of the proteaseE Szabó, Z Böcskei, G Náray-Szabó, et al.
Steroids|September 1, 1995
Microbial transformation of beta-sitosterol and stigmasterol into 26-oxygenated derivativesG Ambrus, E Ilköy, A Jekkel, et al.
Journal Francais D'Ophtalmologie|October 2, 2021
[Paraneoplastic ophthalmopathies]Z Böcskei, E Viinikka, L Dormegny, et al.
Steroids|September 1, 1995
Novel 26-oxygenated products in microbial degradation of ergosterolG Ambrus, A Jekkel, E Ilköy, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
Crystallization and preliminary X-ray analysis of porcine muscle prolyl oligopeptidaseZ Böcskei, M Fuxreiter, G Náray-Szabó, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Acta Pharmaceutica Hungarica|April 7, 1998
[Application of protein crystallography in drug design]Z Böcskei
Cell|August 8, 1998
Prolyl oligopeptidase: an unusual beta-propeller domain regulates proteolysisV Fülöp, Z Böcskei, L Polgár
Acta Pharmaceutica Hungarica|September 1, 1992
[Study of selegiline and related compounds with x-ray diffraction]K Simon, Z Böcskei, Z Török
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1995
Two antithrombotic quinazolone derivativesZ Böcskei, K Simon, L Orfi, et al.
Acta Crystallographica. Section C, Crystal Structure Communications|April 15, 1996
Ipriflavone, an antiostheophorotic agentZ Böcskei, K Simon, M Varga, et al.
European Journal of Biochemistry|August 3, 1999
The three-dimensional structure of Asp189Ser trypsin provides evidence for an inherent structural plasticity of the proteaseE Szabó, Z Böcskei, G Náray-Szabó, et al.
Steroids|September 1, 1995
Microbial transformation of beta-sitosterol and stigmasterol into 26-oxygenated derivativesG Ambrus, E Ilköy, A Jekkel, et al.
Journal Francais D'Ophtalmologie|October 2, 2021
[Paraneoplastic ophthalmopathies]Z Böcskei, E Viinikka, L Dormegny, et al.
Steroids|September 1, 1995
Novel 26-oxygenated products in microbial degradation of ergosterolG Ambrus, A Jekkel, E Ilköy, et al.
Acta Crystallographica. Section D, Biological Crystallography|March 25, 1999
Crystallization and preliminary X-ray analysis of porcine muscle prolyl oligopeptidaseZ Böcskei, M Fuxreiter, G Náray-Szabó, et al.
Pageof 2